1
|
Gornik HL, Aronow HD, Goodney PP, Arya S, Brewster LP, Byrd L, Chandra V, Drachman DE, Eaves JM, Ehrman JK, Evans JN, Getchius TSD, Gutiérrez JA, Hawkins BM, Hess CN, Ho KJ, Jones WS, Kim ESH, Kinlay S, Kirksey L, Kohlman-Trigoboff D, Long CA, Pollak AW, Sabri SS, Sadwin LB, Secemsky EA, Serhal M, Shishehbor MH, Treat-Jacobson D, Wilkins LR. 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2024. [PMID: 38743805 DOI: 10.1161/cir.0000000000001251] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/16/2024]
Abstract
AIM The "2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease" provides recommendations to guide clinicians in the treatment of patients with lower extremity peripheral artery disease across its multiple clinical presentation subsets (ie, asymptomatic, chronic symptomatic, chronic limb-threatening ischemia, and acute limb ischemia). METHODS A comprehensive literature search was conducted from October 2020 to June 2022, encompassing studies, reviews, and other evidence conducted on human subjects that was published in English from PubMed, EMBASE, the Cochrane Library, CINHL Complete, and other selected databases relevant to this guideline. Additional relevant studies, published through May 2023 during the peer review process, were also considered by the writing committee and added to the evidence tables where appropriate. STRUCTURE Recommendations from the "2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease" have been updated with new evidence to guide clinicians. In addition, new recommendations addressing comprehensive care for patients with peripheral artery disease have been developed.
Collapse
|
2
|
Truesdell AG, Cilia L, Serhal M. Just in Case, Just Because, or Just Right? Circ Cardiovasc Interv 2022; 15:e011999. [PMID: 35580201 DOI: 10.1161/circinterventions.122.011999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Affiliation(s)
| | - Lindsey Cilia
- Division of Cardiology, Massachusetts General Hospital, Boston (L.C., M.S.).,Division of Cardiology, Brigham and Women's Hospital, Boston, MA (L.C.)
| | - Maya Serhal
- Division of Cardiology, Massachusetts General Hospital, Boston (L.C., M.S.)
| |
Collapse
|
3
|
Serhal M, Josephson R, Shishehbor M, Frechette K, Henkin S. SVM Communications: Supervised exercise therapy for symptomatic peripheral artery disease - A conversation with the experts. Vasc Med 2022; 27:214-216. [PMID: 35168411 DOI: 10.1177/1358863x221078886] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Affiliation(s)
- Maya Serhal
- Corrigan Minehan Heart Center, Massachusetts General Hospital, Boston, MA, USA
| | - Richard Josephson
- Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.,Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - Mehdi Shishehbor
- Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.,Case Western Reserve University School of Medicine, Cleveland, OH, USA
| | - Kristen Frechette
- Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| | - Stanislav Henkin
- Heart and Vascular Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA
| |
Collapse
|
4
|
Ibrahim M, Serhal M, Feldman S, Pandey S, Jacobs A. THE UTILITY OF POSITRON EMISSION TOMOGRAPHY (PET) MYOCARDIAL PERFUSION IMAGING (MPI) IN THE ASSESSMENT OF CORONARY ARTERY DISEASE IN PATIENTS WITH APICAL HYPERTROPHIC CARDIOMYOPATHY: FRIEND OR FOE? J Am Coll Cardiol 2020. [DOI: 10.1016/s0735-1097(20)34035-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
5
|
Abstract
Venous thromboembolism (VTE) is a common vascular condition. New medications are available to prevent hospital-associated VTE. Strategies are being studied to increase appropriate diagnostic testing utilization. Management of deep vein thrombosis (DVT) and pulmonary embolism (PE) has evolved with the advent of new anticoagulant options and catheter-directed intervention. In light of this, providers are commonly challenged with the decision regarding inpatient versus outpatient management. Which patients require long-term (> 3 months) anticoagulation is challenging and multiple clinical prediction models may be used to help determine the risk-benefit ratio in each patient. The management of VTE is an ongoing area of research and is rapidly evolving.
Collapse
Affiliation(s)
- Maya Serhal
- 1 Cardiovascular Medicine, Department of Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA, USA
| | - Geoffrey D Barnes
- 2 Division of Cardiovascular Medicine, Department of Internal Medicine, Frankel Cardiovascular Center, University of Michigan, Ann Arbor, MI, USA
| |
Collapse
|
6
|
Serhal M, Gornik H, Evans N. In reply: ‘Non-criteria’ antiphospholipid antibodies and thrombosis (February 2018). Cleve Clin J Med 2018; 85:432. [DOI: 10.3949/ccjm.85c.06002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
7
|
Mahar JH, Haddadin I, Sadana D, Gadre A, Evans N, Hornacek D, Mahlay NF, Gomes M, Joseph D, Serhal M, Tong MZY, Bauer SR, Militello M, Silver B, Shishehbor M, Bartholomew JR, Heresi GA. A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic. J Thromb Thrombolysis 2018; 46:186-192. [DOI: 10.1007/s11239-018-1686-2] [Citation(s) in RCA: 21] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
8
|
Serhal M, Evans N, Gornik HL. A 75-year-old with abdominal pain, hypoxia, and weak pulses in the left leg. Cleve Clin J Med 2018; 85:145-154. [DOI: 10.3949/ccjm.85a.16069] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
9
|
Nguyen N, Sharma A, West JK, Serhal M, Brinza E, Gornik HL, Kim ES. Presentation, clinical features, and results of intervention in upper extremity fibromuscular dysplasia. J Vasc Surg 2017; 66:554-563. [DOI: 10.1016/j.jvs.2017.02.049] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2016] [Accepted: 02/27/2017] [Indexed: 11/29/2022]
|
10
|
|
11
|
Serhal M, Mittal A, Khoury M, Brinza E, Fendrikova-Mahlay N, Gornik H, Kim E. FAMILY HISTORY OF ARTERIAL DISORDERS IN PATIENTS WITH SPONTANEOUS CORONARY ARTERY DISSECTION. J Am Coll Cardiol 2017. [DOI: 10.1016/s0735-1097(17)35458-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
12
|
Agarwal S, Serhal M, Shivapour D, Bartholomew JR, Bajzer C. An Unusual Cause of Iatrogenic Hypertension. JACC Cardiovasc Interv 2016; 9:745-6. [PMID: 27056315 DOI: 10.1016/j.jcin.2015.11.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/02/2015] [Accepted: 11/05/2015] [Indexed: 11/30/2022]
Affiliation(s)
- Shikhar Agarwal
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
| | - Maya Serhal
- Department of Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
| | - Daniel Shivapour
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
| | - John R Bartholomew
- Department of Vascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio
| | - Christopher Bajzer
- Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
| |
Collapse
|
13
|
Agarwal S, Serhal M, Shivapour D, Bartholomew J, Bajzer C. AN UNUSUAL CAUSE OF IATROGENIC HYPERTENSION. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)31159-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
14
|
Sullivan CE, Serhal M, Longenecker CT. Cardiovascular surgery outcomes of patients with human immunodeficiency virus infection: New data in the era of combination antiretroviral therapy. J Thorac Cardiovasc Surg 2015; 149:1460. [PMID: 25983253 DOI: 10.1016/j.jtcvs.2014.12.062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/23/2014] [Accepted: 12/23/2014] [Indexed: 10/23/2022]
Affiliation(s)
| | - Maya Serhal
- University Hospitals Case Medical Center, Cleveland, Ohio
| | | |
Collapse
|
15
|
Abstract
Patients with chronic inflammatory diseases are at increased risk for heart failure due to ischemic heart disease and other causes including heart failure with preserved ejection fraction. Using rheumatoid arthritis and treated HIV infection as two prototypical examples, we review the epidemiology and potential therapies to prevent heart failure in these populations. Particular focus is given to anti-inflammatory therapies including statins and biologic disease modifying drugs. There is also limited evidence for lifestyle changes and blockade of the renin-angiotensin-aldosterone system. We conclude by proposing how a strategy for heart failure prevention, such as the model tested in the Screening To Prevent Heart Failure (STOP-HF) trial, may be adapted to chronic inflammatory disease.
Collapse
Affiliation(s)
- Maya Serhal
- University Hospitals Case Medical Center, Cleveland, OH, USA
| | - Chris T Longenecker
- University Hospitals Case Medical Center, Cleveland, OH, USA ; Case Western Reserve University School of Medicine, Cleveland, OH, USA
| |
Collapse
|